Despite longstanding recognition of HIF1α as a master regulator of hypoxic adaptation, the precise mechanisms through which HIF1α influences lineage-specific transcriptional networks and therapeutic resistance in prostate cancer remain incompletely defined. The gene discussed is HIF1A; the disease is prostate carcinoma.